Breakthrough in Early Cancer Detection: New Blood Tests Revolutionize Diagnosis

If you’ve walked the trails along Lady Bird Lake this spring, you’ve probably noticed the same thing I have: more people than ever wearing those bright yellow Livestrong wristbands. It’s not just a fashion statement. Austinites are talking about cancer—specifically, how to catch it before it becomes a death sentence. And now, thanks to a partnership announced this week between two companies you might not have heard of yet, that conversation just got a lot more urgent.

Evexia Diagnostics and Cancer Check Labs have joined forces to bring what they’re calling the first “physician-grade” multi-cancer early detection test to the U.S. Market. The test, branded as CancerCheck, isn’t just another blood draw. It’s a full pathology report, signed by a board-certified pathologist, that can detect more than 200 types of solid tumor cancers—including breast, lung, prostate, and pancreatic—before symptoms even appear. And it’s doing this by looking for something most other tests miss: whole circulating tumor cells (CTCs), the actual malignant cells that break away from a tumor and enter the bloodstream.

For a city like Austin, where the tech industry’s obsession with “disruption” often feels like it’s more about apps than actual lives, this is different. This is disruption with stakes. One in three women and one in two men in the U.S. Will be diagnosed with cancer in their lifetime, according to Cancer Check Labs’ founder, Sumit Rai. And in Texas, where the cancer mortality rate is higher than the national average—especially for lung, colorectal, and liver cancers—early detection isn’t just a medical breakthrough. It’s a public health imperative.

The Science Behind the Headlines: Why This Isn’t Just Another Cancer Test

Most of us have heard of liquid biopsies by now. Companies like Grail and Guardant Health have made headlines for their blood tests that scan for fragments of tumor DNA. But CancerCheck takes a different approach. Instead of looking for broken bits of genetic material, it isolates and examines whole circulating tumor cells—intact cells that have broken away from a solid tumor and are now floating in the bloodstream. These cells aren’t just markers of risk. they’re direct evidence of active cancer.

Here’s how it works: A patient gets a standard blood draw, usually at a clinic or lab. That sample is sent to Cancer Check Labs, where proprietary filtration technology separates out the CTCs. Those cells are then affixed to a slide and stained using the same gold-standard methods pathologists leverage for tissue biopsies. Finally, an independent, board-certified pathologist reviews the slides under a microscope, just like they would for a traditional biopsy. The result isn’t a probability score or a “cancer signal detected” alert. It’s a pathology report—a document that a doctor can use to make real clinical decisions.

Jim Ciardella, Cancer Check Labs’ Chief Commercial Officer, put it this way in a recent PR Newswire release: “The CancerCheck process is exactly analogous to what happens in a solid tissue biopsy. The only difference is we’re extracting the tissue at a cellular level from a blood sample rather than surgically cutting to procure tissue, which creates, a whole-body tissue biopsy.”

This isn’t just a semantic difference. It’s a fundamental shift in how we perceive about cancer screening. Most liquid biopsies today rely on algorithms to interpret fragmented DNA or protein markers. They’re fine at flagging potential red flags, but they can’t advise you definitively whether cancer is present. CancerCheck, by contrast, is designed to provide a yes-or-no answer—one that’s backed by a human expert, not just a machine learning model.

That human element matters, especially in a state like Texas, where rural communities often lack access to specialized oncologists. A pathology report from CancerCheck could give a primary care physician in, say, Lockhart or Bastrop the same level of diagnostic confidence as a specialist at Dell Seton Medical Center. And in a city where traffic on I-35 can turn a 20-minute drive to a specialist into a two-hour ordeal, that kind of decentralized care could be a game-changer.

The Austin Angle: Why This Partnership Matters Here

Evexia Diagnostics, the company partnering with Cancer Check Labs, isn’t based in Austin—it’s headquartered in Florida. But its role in this partnership is critical for local healthcare providers. Evexia specializes in diagnostic testing services, and its network includes labs across the country. That means Austin’s clinics, hospitals, and even some employer-sponsored wellness programs could soon have access to CancerCheck without needing to send samples out of state.

For a city that’s become a magnet for biotech startups—thanks in part to the Dell Medical School at UT Austin and the growing presence of companies like Molecular Templates and Asuragen—this is the kind of innovation that could solidify Austin’s reputation as a hub for cutting-edge healthcare. It’s also a potential boon for the city’s large population of remote workers, many of whom have the flexibility to prioritize preventive care but may not have easy access to top-tier specialists.

But there’s a catch. CancerCheck isn’t cheap. While the exact price hasn’t been publicly disclosed, similar multi-cancer early detection tests typically run anywhere from $500 to $1,500—and they’re rarely covered by insurance. For a city where the median household income is around $88,000 (higher than the national average but still stretched thin by rising housing costs), that’s a significant barrier. And in Travis County, where nearly 12% of residents are uninsured—the highest rate in the state—access to this kind of test could be limited to those who can afford to pay out of pocket.

That disparity is something local policymakers and healthcare advocates will need to grapple with. The Travis County Commissioners Court, for example, has been vocal about expanding access to preventive care, especially for underserved communities. If CancerCheck proves as effective as its backers claim, it could become a key part of that conversation. The same goes for the Central Health board, which oversees healthcare services for low-income residents in Travis County. If this test can detect cancer at Stage 0—when survival rates are as high as 99%—it could save lives and reduce long-term healthcare costs.

There’s also the question of how this will integrate with existing screening programs. The Seton Healthcare Family, now part of Ascension Texas, already offers a range of cancer screenings, from mammograms to colonoscopies. But those tests are typically recommended based on age, gender, or family history. CancerCheck, by contrast, is designed to be a universal screening tool—one that could theoretically be used by anyone, regardless of risk factors. That’s a paradigm shift, and it’s one that local providers will need to navigate carefully.

The Skepticism Factor: What’s Not Being Said

For all its promise, CancerCheck isn’t without controversy. The U.S. Food and Drug Administration (FDA) hasn’t yet approved any multi-cancer early detection test for broad clinical use. Grail’s Galleri test, one of the most well-known in this space, is available only through a prescription and comes with a disclaimer that it’s not a replacement for standard screenings. CancerCheck operates in a similar gray area. According to its own website, the test is “not intended to diagnose, treat, cure, or prevent any disease” and “should not replace established, evidence-based screening, diagnostic, or treatment protocols.”

That’s a critical caveat. No matter how advanced a blood test is, it can’t replace a colonoscopy for colorectal cancer or a mammogram for breast cancer. And while CancerCheck’s ability to detect more than 200 cancer types is impressive, it’s not foolproof. False positives and false negatives are still possible, and the test’s sensitivity—its ability to correctly identify people who have cancer—varies depending on the type and stage of the disease.

There’s also the question of what happens after a positive result. If CancerCheck flags potential cancer, the next step is typically a follow-up test, like a PET scan or a tissue biopsy. In Austin, where wait times for imaging services can stretch for weeks, that could create bottlenecks. And for patients without insurance, the cost of those follow-up tests could be prohibitive.

Then there’s the psychological toll. A positive result from a cancer screening test—even a preliminary one—can be devastating. Austin’s mental health providers, already stretched thin, may see an uptick in demand for counseling services as more people undergo these kinds of tests. Organizations like the Livestrong Foundation, which provides support for cancer patients and survivors, could also see an increase in calls from people navigating the emotional fallout of early detection.

What Which means for Austin’s Healthcare Ecosystem

So where does this leave us? For starters, it’s a reminder that Austin’s healthcare landscape is evolving—and fast. The city’s growing biotech sector, combined with its reputation as a hub for innovation, makes it a prime testing ground for latest medical technologies. But it’s also a city where healthcare disparities are stark. The same week that CancerCheck’s partnership was announced, the Texas Tribune reported that Travis County’s uninsured rate remains stubbornly high, even as the state’s economy booms. That’s a tension that won’t be resolved overnight.

For local employers, this could be an opportunity to differentiate themselves. Companies like Whole Foods, and Tesla—all of which have a significant presence in Austin—offer robust health benefits to attract and retain talent. Adding CancerCheck to their wellness programs could be a way to stand out, especially for employees who are at higher risk for cancer due to family history or lifestyle factors. The Austin Chamber of Commerce, which has been vocal about the need to improve healthcare access for the city’s workforce, could play a role in facilitating those conversations.

For patients, the message is clear: early detection saves lives, but it’s not a silver bullet. If you’re considering a test like CancerCheck, it’s worth having a conversation with your doctor about the pros, and cons. And if you’re uninsured or underinsured, it’s worth exploring whether local programs—like those offered by Central Health or the Livestrong Cancer Institutes—can help cover the cost.

Given My Background in Public Health, Here’s Who You Should Talk to in Austin

If this news has you thinking about your own health—or the health of someone you love—here’s who you should be talking to in the Austin area. These aren’t just generic recommendations; they’re the kinds of professionals who can help you navigate the complexities of early cancer detection, especially in light of this new partnership.

Board-Certified Pathologists with Experience in Liquid Biopsies

Why you need one: CancerCheck’s pathology reports are only as good as the experts interpreting them. A pathologist with experience in liquid biopsies can help you understand what a positive or negative result really means—and what your next steps should be.

What to gaze for:

• Board certification in anatomic and clinical pathology, with additional training in molecular diagnostics or cytopathology.
• Affiliation with a major hospital system (e.g., Ascension Texas, Baylor Scott & White, or St. David’s Healthcare) or a reputable independent lab.
• Experience interpreting circulating tumor cell (CTC) tests or other advanced liquid biopsy technologies.
• A track record of clear, patient-friendly communication. Pathology reports can be dense; you seek someone who can translate the jargon.

Where to start: The Dell Medical School at UT Austin has a growing pathology department, and many of its faculty members are involved in cutting-edge research. The Texas Society of Pathologists (directory here) also maintains a list of board-certified pathologists in the state.

Oncology-Focused Genetic Counselors

Why you need one: Even if CancerCheck isn’t a genetic test, its results can raise questions about your cancer risk. A genetic counselor can help you understand whether you should consider additional genetic testing (e.g., for BRCA mutations) and how to interpret your family history in light of your results.

What to look for:

• Certification through the American Board of Genetic Counseling (ABGC) or the American Board of Medical Genetics and Genomics (ABMGG).
• Specialization in cancer genetics, with experience working with patients who have undergone liquid biopsies or other early detection tests.
• Affiliation with a comprehensive cancer center, like the Livestrong Cancer Institutes at UT Austin or the Texas Oncology network.
• A counseling approach that’s both evidence-based and empathetic. Cancer risk can be a sensitive topic; you want someone who can guide you without overwhelming you.

Where to start: The National Society of Genetic Counselors (find a counselor here) has a searchable database. In Austin, the Livestrong Cancer Institutes and Texas Oncology both offer genetic counseling services.

Patient Navigators Specializing in Early Cancer Detection

Why you need one: If CancerCheck—or any other early detection test—comes back with a concerning result, you’ll need help navigating the next steps. A patient navigator can guide you through follow-up tests, specialist referrals, and even insurance appeals if your claims are denied.

What to look for:

• Certification through the Academy of Oncology Nurse & Patient Navigators (AONN+) or a similar organization.
• Experience working with patients who have undergone liquid biopsies or other non-invasive cancer screenings.
• Affiliation with a hospital or cancer center that offers a robust navigation program (e.g., Dell Seton Medical Center, St. David’s South Austin Medical Center).
• A proactive approach to problem-solving. You want someone who will advocate for you, not just hand you a list of phone numbers.

Where to start: The American Cancer Society’s Patient Navigator Program (find a navigator here) is a great resource. In Austin, the Livestrong Foundation also offers navigation services for cancer patients and survivors.

This isn’t just about finding the “best” provider—it’s about finding the right one for your specific situation. If you’re at high risk for cancer due to family history, for example, you might prioritize a genetic counselor with a strong oncology background. If you’re uninsured, a patient navigator who understands the local safety-net system could be invaluable. And if you’re simply trying to make sense of your CancerCheck results, a pathologist with experience in liquid biopsies is your best bet.

Ready to find trusted professionals? Browse our complete directory of top-rated early cancer detection experts in the Austin area today.